CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 54 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $50,078 | -66.9% | 115,414 | -50.0% | 0.00% | – |
| Q4 2022 | $151,470 | +53.0% | 230,828 | +100.0% | 0.00% | – |
| Q3 2022 | $99,000 | +57.1% | 115,414 | 0.0% | 0.00% | – |
| Q2 2022 | $63,000 | -50.8% | 115,414 | -0.1% | 0.00% | – |
| Q1 2022 | $128,000 | -33.0% | 115,549 | +4.3% | 0.00% | – |
| Q4 2021 | $191,000 | -30.5% | 110,821 | +23.5% | 0.00% | – |
| Q3 2021 | $275,000 | -15.4% | 89,721 | +7.7% | 0.00% | – |
| Q2 2021 | $325,000 | -70.9% | 83,321 | -79.2% | 0.00% | – |
| Q1 2021 | $1,116,000 | -14.7% | 400,146 | -6.4% | 0.00% | – |
| Q4 2020 | $1,308,000 | -51.0% | 427,301 | -2.7% | 0.00% | – |
| Q3 2020 | $2,670,000 | -9.6% | 439,072 | -12.2% | 0.00% | – |
| Q2 2020 | $2,955,000 | +107.5% | 500,080 | -6.9% | 0.00% | – |
| Q1 2020 | $1,424,000 | -0.6% | 537,316 | +2.0% | 0.00% | – |
| Q4 2019 | $1,433,000 | -73.9% | 526,667 | +16.3% | 0.00% | – |
| Q3 2019 | $5,491,000 | +12.3% | 453,024 | +6.1% | 0.00% | – |
| Q2 2019 | $4,891,000 | – | 427,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |